amphotericin b deoxycholate is the most common treatment antifungal agent used to treat candida infections. topical antifungal agents are commonly taken in 3 forms: oral suspension, ointment and powder. oral suspension is mainly used to treat thrush whereas ointment is directly applied onto the infected section. nystatin is a type of antifungal agent used because it is not absorbed by the gastrointestinal tract. these types of agents will function to lower candida species’ phospholipases activities. flucytosine (5fc) is another type of therapy treatment including 3 agents used; caspofungin, micafungin and anidulafungin. usage of caspofungin will efficiently target against oropharyngeal and oesophageal candidiasis and invasive candidiasis. micafungin, compared to amphotericin b, it is more efficient. anidulafungin results are similar to caspofungin and micafungin. echinocandin are a type of non-competitive inhibitors of cell wall 1,3-b-d-glucan synthase complex mainly used to treat fungal infections. azoles are agents that can deplete ergosterol, the main component of the fungus cell wall membrane, in order to inhibit fungal growth. fluconazole is water-soluble, ready to be taken orally. c. tropicalis can rapidly develop resistance towards fluconazole therefore it's not recommended to retreat fluconazole-treated patients with recurrent candidiasis. other azoles that are highly active against c. tropicalis are itraconazole, voriconazole, posaconazole, ravuconazole and isavuconazole. voriconazole is a new generation from fluconazole with a higher potential of broad spectrum activity. all of the mentioned treatments and drug therapies can also be applied onto neonates and premature newborns taking into account the amount of recommended dose. although there are several ways to treat the different types of c. tropicalis’ infections, the best way to improve treatments results is to improve host immune system.